首页> 美国卫生研究院文献>BMC Veterinary Research >Expression and role of PGP BCRP MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells
【2h】

Expression and role of PGP BCRP MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells

机译:PGPBCRPMRP1和MRP3在犬乳腺癌细胞多药耐药中的表达及其作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIn both women and female dogs, the most prevalent type of malignant neoplasm is the spontaneous mammary tumor. In dogs, half of these are malignant. The treatment of choice for the canine patients is surgical mastectomy. Unfortunately, it often fails in high-risk, locally invasive mammary tumors as of during the time of the surgery the micro-metastases are present. Moreover, there are neither large studies conducting to prove of the benefit from the chemotherapy in dogs nor established chemotherapy treatment protocols available. Additionally, the effectiveness of each individual chemotherapeutic agent and drug resistance of canine mammary cancer have not yet been characterized. That has become the aim of our study, to assess the expression of PGP, BCRP, MRP1 and MRP3 in canine mammary cancer cell lines and to investigate their role in cancer resistance to vinblastine, cisplatin and cyclophosphamide with using RNAi approach.
机译:背景在雌性和雌性狗中,最普遍的恶性肿瘤类型是自发性乳腺肿瘤。在狗中,其中一半是恶性的。犬类患者的治疗选择是手术乳房切除术。不幸的是,在外科手术期间存在微转移的情况下,它在高危,局部浸润性乳腺肿瘤中常常失败。此外,既没有进行大的研究来证明从狗中进行化学疗法的益处,也没有建立可用的化学疗法治疗方案。另外,还没有表征每种单独的化学治疗剂的有效性和犬乳癌的耐药性。这已经成为我们研究的目的,使用RNAi方法评估PGP,BCRP,MRP1和MRP3在犬乳癌细胞系中的表达,并研究它们在对长春碱,顺铂和环磷酰胺的抗癌性中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号